CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- +154.1%
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) Price to free cash flow
As of 6 November 2026, CVS Health Corporation (CVS) trades at a price to free cash flow of 6.9×. Over the past ten years it has ranged from 4.7× (August 2023) to 50.3× (October 2024); the current reading is higher than 11% of that period. That is below the Healthcare Plans industry median of 14.8× and below the Healthcare sector median of 20.5×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 12.9× | 44.16% |
| FY2024 | 8.9× | (10.61%) |
| FY2023 | 10.0× | 10.28% |
| FY2022 | 9.1× | 4.87% |
| FY2021 | 8.6× | 29.80% |
| FY2020 | 6.7× | (28.42%) |
| FY2019 | 9.3× | (7.15%) |
| FY2018 | 10.0× | (18.66%) |
| FY2017 | 12.3× | 13.09% |
| FY2016 | 10.9× | (38.16%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 7.1× | (37.29%) |
| Jun 2026 | 11.3× | (8.99%) |
| Mar 2026 | 12.4× | (3.99%) |
| Dec 2025 | 12.9× | (15.28%) |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| OSCR Oscar Health, Inc. compare | 2.3× |
| CVS CVS Health Corporation | 6.9× |
| CNC Centene Corporation compare | 8.7× |
| CI Cigna Group compare | 9.3× |
| ELV Elevance Health, Inc. compare | 14.2× |
| PGNY Progyny, Inc. compare | 14.8× |
| UNH UnitedHealth Group Incorporated compare | 15.5× |
| HUM Humana Inc. compare | 16.5× |
| MOH Molina Healthcare, Inc compare | 44.8× |
| Healthcare Plans industry median | 14.8× |
| Healthcare sector median | 20.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement